Power3 Medical Products, Inc. (OTC:PWRM)
PWRM, a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. PWRM's products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease. PWRM's products analyze proteins and their mutations to assess an individual's risk for developing disease later in life or a patient's likelihood of responding to a particular drug; assess a patient's risk of disease progression and disease recurrence; and measure a patient's exposure to drug therapy. PWRM was formerly known as Surgical Safety Products, Inc. and changed its name to Power3 Medical Products, Inc. in September 2003. PWRMwas founded in 1992 and is based in The Woodlands, Texas.
PWRM, a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced earlier this month that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (NASDAQ:ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro, PWRM's diagnostic test, and focused on PWRM's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.
PWRM has filed several patent applications for its NuroPro technology that are currently pending. PWRM also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, PWRM has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. PWRM intends to publish these latest findings as well.
To learn more about PWRM visit: http://www.Power3Medical.com
Furmanite Corporation (NYSE:FRM)
Kendall Law Group, a national securities firm led by a former federal judge with attorneys that include a former U.S. Attorney, is investigating FRM for shareholders. The investigation concerns potential breaches of fiduciary duties by the board of directors and other company executives based upon allegations from a confidential source. Concerned FRM shareholders are urged to contact Joe Kendall of the Kendall Law Group at 877-744-3728 or by email at email@example.com.
FRM, through its subsidiaries, provides technical services in Europe, North America, Latin America, the Middle East, Africa, and the Asia Pacific. FRM was formerly known as Xanser Corporation and changed its name to Furmanite Corporation in May 2007. FRM was founded in 1952 and is headquartered in Richardson, Texas.
To learn more about FRM visit: http://www.furmanite.com
Fuwei Films (Holdings) Co., Ltd. (NASDAQ:FFHL)
FFHL, a manufacturer and distributor of high-quality BOPET plastic film located in China, recently announced that its 2010 Annual General Meeting, originally scheduled to be held on September 16, 2010 and adjourned to September 23, 2010, was dissolved for lack of a quorum in accordance with FFHL's Articles of Association.
The current directors of FFHL will continue to hold office until the 2011. AGM and Kabani & Company, Inc. will continue to serve as FFHL's Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2010.
FFHL, together with its subsidiaries, engages in the development, manufacture, and distribution of plastic film using the biaxial oriented stretch technique, known as BOPET film (biaxially oriented polyethylene terephthalate). FFHL markets its products under the Fuwei Films brand name. FFHL exports its products to packaging customers and distributors primarily in South Korea, the United States, and Europe. FFHL was founded in 2003 and is headquartered in Weifang, the People's Republic of China.
To learn more about FFHL visit: http://www.fuweiholdings.com
FX Energy, Inc. (Nasdaq:FXEN)
FXEN this week reported that the Lisewo well has started drilling on FXEN's 850,000 acre Fences concession in western Poland. The well is planned to test a 3-D defined Rotliegend sandstone structural target. Expected total depth of the well is 3,945 meters. FXEN owns 49% of the Lisewo well. The Polish Oil & Gas Company is the operator and owns 51%.
"The Lisewo prospect has the best risk-to-reward ratio of any well in the history of the Company," said David Pierce CEO of FXEN. "Because of the potential size of the prospect, a success at Lisewo could lead to one or more additional drilling locations in this same area. We expect to see initial results from the well in 3 to 4 months."
FXEN, together with its subsidiaries, operates as an independent oil and gas exploration and production company with principal operations in Poland. As of December 31, 2009, FXEN's total proved estimated oil and gas reserves were 50.4 billion cubic feet of natural gas equivalent. FXEN was founded in 1989 and is headquartered in Salt Lake City, Utah.
To learn more about FXEN visit: http://www.fxenergy.com
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has previously received five hundred thousand shares as compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (OTC:PWRM). Recently, Crown Equity Holdings Inc. had received an additional amount of 2,000,000 shares of free trading stock for 60 days of media advertisement, web design and maintenance for Power 3 Medical Products Inc. (OTC:PWRM). Each advertising commitment has now expired.
Disclosure: No positions